Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Blüthgen, Nils (1) Bunse, Mario Dr. (3) Chen, Wei Prof. Dr. (2) Daumke, Oliver Prof. Dr. (2) Dittmar, Gunnar Dr. (1) Edes, Inan Dr. (1) Fälber, Katja Dr. (1) Hammes-Lewin, Annette Dr. (1) Heinemann, Udo Prof. Dr. (1) Hirsekorn, Antje (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (2) Kammertöns, Thomas Dr. (2) Kärgel, Eva Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Klußmann, Enno PD Dr. (1) Ku, Min-Chi Dr. (1) Landthaler, Markus Prof. Dr. (2) Lewin, Gary Prof. Dr. (1) Lorenz, Felix Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (6) Niendorf, Thoralf Prof. Dr. (1) Obermayer, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Panakova, Daniela Dr. (1) Patone, Giannino Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rocks, Oliver Dr. (2) Roske, Yvette Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schmidt, Karin (1) Selbach, Matthias Prof. Dr. (10) Uckert, Wolfgang Prof. Dr. (12) Waiczies, Helmar Dr. (1) Waiczies, Sonia Dr. (1) Wanker, Erich Prof. Dr. (1) Wolf, Susanne Dr. (1) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zühlke, Kerstin Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (5) (-) Leisegang, Matthias Dr. (3) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (5) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) (-) Molekulare Immunologie und Gentherapie (5) (-) Molekulare Zellbiologie und Gentherapie (4) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (12) 2004 (10) 2005 (12) (-) 2006 (5) 2007 (7) 2008 (8) 2009 (5) 2011 (9) 2013 (13) 2014 (6) 2015 (7) (-) 2016 (6) 2017 (10) 2018 (5) 2019 (6) 2020 (5) 2021 (7) 2022 (7) 11 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie Molekulare Zellbiologie und Gentherapie20062016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 17. Oktober 2016 in J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein 22. Juli 2016 in PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler 01. Juni 2016 in Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber 03. Mai 2016 in Proc Natl Acad Sci U S A Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells E. Derudder S. Herzog V. Labi T. Yasuda K. Köchert M. Janz A. Villunger M. Schmidt-Supprian K. Rajewsky 07. April 2016 in Nat Biotechnol Receptor combinations hone T-cell therapy T. Blankenstein 01. März 2016 in J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
17. Oktober 2016 in J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
22. Juli 2016 in PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler
01. Juni 2016 in Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber
03. Mai 2016 in Proc Natl Acad Sci U S A Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells E. Derudder S. Herzog V. Labi T. Yasuda K. Köchert M. Janz A. Villunger M. Schmidt-Supprian K. Rajewsky
01. März 2016 in J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
